{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T16:00:39Z","timestamp":1771862439189,"version":"3.50.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Project of Invigorating Health Care through Science, Technology and Education, Jiangsu Provincial Key Medical Discipline Cultivation Unit","award":["JSDW202250"],"award-info":[{"award-number":["JSDW202250"]}]},{"name":"Project of Invigorating Health Care through Science, Technology and Education, Jiangsu Provincial Key Medical Discipline Cultivation Unit","award":["JSDW202250"],"award-info":[{"award-number":["JSDW202250"]}]},{"name":"Project of Invigorating Health Care through Science, Technology and Education, Jiangsu Provincial Key Medical Discipline Cultivation Unit","award":["JSDW202250"],"award-info":[{"award-number":["JSDW202250"]}]},{"name":"Project of Invigorating Health Care through Science, Technology and Education, Jiangsu Provincial Key Medical Discipline Cultivation Unit","award":["JSDW202250"],"award-info":[{"award-number":["JSDW202250"]}]},{"name":"Huai\u2019an Science and Technology Bureau Natural Science Research Project","award":["HAB202135"],"award-info":[{"award-number":["HAB202135"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104303"],"award-info":[{"award-number":["82104303"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00228-025-03970-z","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T02:58:21Z","timestamp":1769137101000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The effectiveness and safety of oral anticoagulation therapy in patients undergoing transcatheter aortic valve replacement: a systematic review\/meta-analysis"],"prefix":"10.1007","volume":"82","author":[{"given":"Qiang","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanzi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"key":"3970_CR1","doi-asserted-by":"crossref","unstructured":"G\u00e9n\u00e9reux P, Sharma RP, Cubeddu RJ et al (2023) The Mortality Burden of Untreated Aortic Stenosis. J Am Coll Cardiol 82(22):2101\u20132109.","DOI":"10.1016\/j.jacc.2023.09.796"},{"issue":"5","key":"3970_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2024.102478","volume":"49","author":"Q Zou","year":"2024","unstructured":"Zou Q, Wei Z, Sun S (2024) Complications in transcatheter aortic valve replacement: a comprehensive analysis and management strategies. Curr Prob Cardiol 49(5):102478","journal-title":"Curr Probl Cardiol"},{"key":"3970_CR3","first-page":"e72","volume":"143","author":"CM Otto","year":"2021","unstructured":"Otto CM, Nishimura RA, Bonow RO et al (2021) 2020 ACC\/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 143:e72\u2013e227","journal-title":"Circulation"},{"issue":"7","key":"3970_CR4","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","volume":"43","author":"A Vahanian","year":"2021","unstructured":"Vahanian A, Beyersdorf F, Praz F et al (2021) 2021 ESC\/EACTS guidelines for the management of valvular heart disease. Eur Heart J 43(7):561\u2013632","journal-title":"Eur Heart J"},{"issue":"5","key":"3970_CR5","doi-asserted-by":"publisher","first-page":"e207","DOI":"10.1016\/j.chest.2022.07.025","volume":"162","author":"JD Douketis","year":"2022","unstructured":"Douketis JD, Spyropoulos AC, Murad MH et al (2022) Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline. Chest 162(5):e207-243","journal-title":"Chest"},{"issue":"2","key":"3970_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jcin.2020.10.026","volume":"14","author":"V Auffret","year":"2021","unstructured":"Auffret V, Leurent G, Le Breton H (2021) Oral anticoagulation continuation throughout TAVR: high risk-high reward or marginal gains? JACC Cardiovasc Interv 14(2):145\u2013148","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"3970_CR7","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.023561","volume":"11","author":"T Tanawuttiwat","year":"2022","unstructured":"Tanawuttiwat T, Stebbins A, Marquis-Gravel G et al (2022) Use of direct oral anticoagulant and outcomes in patients with atrial fibrillation after transcatheter aortic valve replacement: insights from the STS\/ACC TVT registry. J Am Heart Assoc 11(1):e023561","journal-title":"J Am Heart Assoc"},{"issue":"22","key":"3970_CR8","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1136\/heartjnl-2023-322548","volume":"109","author":"C Hohmann","year":"2023","unstructured":"Hohmann C, Pfister R, Frerker C et al (2023) Direct oral anticoagulants versus vitamin K antagonist after transcatheter aortic valve implantation. Heart 109(22):1706\u20131713","journal-title":"Heart"},{"issue":"23","key":"3970_CR9","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1056\/NEJMoa2111016","volume":"385","author":"NM Van Mieghem","year":"2021","unstructured":"Van Mieghem NM, Unverdorben M, Hengstenberg C et al (2021) Edoxaban versus vitamin K antagonist for atrial fibrillation after TAVR. N Engl J Med 385(23):2150\u20132160","journal-title":"N Engl J Med"},{"issue":"12","key":"3970_CR10","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.rec.2024.03.013","volume":"77","author":"A Alperi","year":"2024","unstructured":"Alperi A, Ptaszynski R, Pascual I et al (2024) Late bleeding events in TAVI patients receiving vitamin K antagonists or direct oral anticoagulants. Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition) 77(12):976\u2013984","journal-title":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"},{"issue":"3","key":"3970_CR11","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jcin.2023.11.038","volume":"17","author":"B Alaour","year":"2024","unstructured":"Alaour B, Ferrari E, Heg D et al (2024) Non-vitamin K antagonist versus vitamin K antagonist oral anticoagulant agents after transcatheter aortic valve replacement. JACC Cardiovasc Interv 17(3):405\u2013418","journal-title":"JACC Cardiovasc Interv"},{"issue":"18","key":"3970_CR12","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","volume":"380","author":"MJ Mack","year":"2019","unstructured":"Mack MJ, Leon MB, Thourani VH et al (2019) Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med 380(18):1695\u20131705","journal-title":"N Engl J Med"},{"issue":"18","key":"3970_CR13","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1056\/NEJMoa1816885","volume":"380","author":"JJ Popma","year":"2019","unstructured":"Popma JJ, Deeb GM, Yakubov SJ et al (2019) Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med 380(18):1706\u20131715","journal-title":"N Engl J Med"},{"key":"3970_CR14","doi-asserted-by":"crossref","unstructured":"Salameh JP, Bossuyt PM, McGrath TA et al (2020) Preferred reporting items for systematic review and meta-analysis of diagnostic test accuracy studies (PRISMA-DTA): explanation, elaboration, and checklist. BMJ 370:m2632.","DOI":"10.1136\/bmj.m2632"},{"key":"3970_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898","journal-title":"BMJ"},{"key":"3970_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919","journal-title":"BMJ"},{"key":"3970_CR17","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.jacc.2012.09.001","volume":"60","author":"AP Kappetein","year":"2012","unstructured":"Kappetein AP, Head SJ, G\u00e9n\u00e9reux P et al (2012) Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol 60:1438\u20131454","journal-title":"J Am Coll Cardiol"},{"issue":"19","key":"3970_CR18","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1093\/eurheartj\/ehaa799","volume":"42","author":"P G\u00e9n\u00e9reux","year":"2021","unstructured":"G\u00e9n\u00e9reux P, Piazza N, Alu MC et al (2021) Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research. Eur Heart J 42(19):1825\u20131857","journal-title":"Eur Heart J"},{"issue":"4","key":"3970_CR19","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"S Schulman","year":"2005","unstructured":"Schulman S, Kearon C (2005) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 3(4):692\u2013694","journal-title":"J Thromb Haemost"},{"key":"3970_CR20","unstructured":"van Ginkel DJ, Bor WL, Aarts HM et al (2024) Continuation versus Interruption of Oral Anticoagulation during TAVI. New Engl J Med."},{"issue":"2","key":"3970_CR21","first-page":"135","volume":"14","author":"M Brinkert","year":"2021","unstructured":"Brinkert M, Mangner N, Moriyama N et al (2021) Safety and efficacy of transcatheter aortic valve replacement with continuation of vitamin K antagonists or direct oral anticoagulants. JACC Cardiovasc Interv 14(2):135\u2013144","journal-title":"JACC: Cardiovascular Interventions"},{"key":"3970_CR22","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.amjcard.2021.03.022","volume":"149","author":"AP Tagliari","year":"2021","unstructured":"Tagliari AP, Perez-Camargo D, Ferrari E et al (2021) Pre-operative continued oral anticoagulation impact on early outcomes after transcatheter aortic valve implantation. Am J Cardiol 149:64\u201371","journal-title":"Am J Cardiol"},{"issue":"7","key":"3970_CR23","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.amjcard.2018.12.042","volume":"123","author":"N Mangner","year":"2019","unstructured":"Mangner N, Crusius L, Haussig S et al (2019) Continued Versus Interrupted Oral Anticoagulation During Transfemoral Transcatheter Aortic Valve Implantation and Impact of Postoperative Anticoagulant Management on Outcome in Patients With Atrial Fibrillation. Am J Cardiol 123(7):1134\u20131141","journal-title":"Am J Cardiol"},{"key":"3970_CR24","doi-asserted-by":"crossref","unstructured":"Skogseid EL, Batra G, Westerbergh J et al (2024) Thromboembolic and bleeding events after valvular intervention in patients with atrial fibrillation. Open Heart 11(1)","DOI":"10.1136\/openhrt-2024-002602"},{"issue":"13","key":"3970_CR25","doi-asserted-by":"publisher","first-page":"e1066","DOI":"10.4244\/EIJ-D-22-00521","volume":"18","author":"N Mangner","year":"2023","unstructured":"Mangner N, Brinkert M, Keller LS et al (2023) Continued non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists during transcatheter aortic valve implantation. Eurointervention 18(13):e1066-1076","journal-title":"Eurointervention"},{"issue":"8","key":"3970_CR26","first-page":"838","volume":"51","author":"YH Sun","year":"2023","unstructured":"Sun YH, Li J, Luo SY et al (2023) Short-term outcome of patients after transcatheter aortic valve replacement receiving different anticoagulants. Zhonghua Xin Xue Guan Bing Za Zhi 51(8):838\u2013843","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"3970_CR27","doi-asserted-by":"crossref","unstructured":"Collet JP, Van Belle E, Thiele H et al (2022) Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial. Eur Heart J 43(29):2783\u20132797.","DOI":"10.1093\/eurheartj\/ehac408"},{"key":"3970_CR28","doi-asserted-by":"crossref","unstructured":"Watanabe Y, Hayashida K, Yamamoto M et al (2022) Edoxaban vs. Vitamin K Antagonist for Atrial Fibrillation After Transcatheter Aortic Valve Replacement in Japanese Patients. Circ J 86(11):1756\u20131763","DOI":"10.1253\/circj.CJ-22-0093"},{"issue":"1","key":"3970_CR29","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s11239-019-01968-w","volume":"50","author":"K Kalogeras","year":"2020","unstructured":"Kalogeras K, Jabbour RJ, Ruparelia N et al (2020) Comparison of warfarin versus DOACs in patients with concomitant indication for oral anticoagulation undergoing TAVI; results from the ATLAS registry. J Thromb Thrombolysis 50(1):82\u201389","journal-title":"J Thromb Thrombolysis"},{"issue":"16","key":"3970_CR30","first-page":"1580","volume":"12","author":"I Kosmidou","year":"2019","unstructured":"Kosmidou I, Liu Y, Alu MC et al (2019) Antithrombotic therapy and cardiovascular outcomes after transcatheter aortic valve replacement in patients with atrial fibrillation. JACC Cardiovasc Interv 12(16):1580\u20131589","journal-title":"JACC: Cardiovascular Interventions"},{"issue":"16","key":"3970_CR31","first-page":"1566","volume":"12","author":"D Jochheim","year":"2019","unstructured":"Jochheim D, Barbanti M, Capretti G et al (2019) Oral anticoagulant type and outcomes after transcatheter aortic valve replacement. JACC Cardiovasc Interv 12(16):1566\u20131576","journal-title":"JACC: Cardiovascular Interventions"},{"issue":"9","key":"3970_CR32","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s00392-018-1247-x","volume":"107","author":"NA Geis","year":"2018","unstructured":"Geis NA, Kiriakou C, Chorianopoulos E et al (2018) NOAC monotherapy in patients with concomitant indications for oral anticoagulation undergoing transcatheter aortic valve implantation. Clin Res Cardiol 107(9):799\u2013806","journal-title":"Clin Res Cardiol"},{"issue":"1","key":"3970_CR33","first-page":"66","volume":"10","author":"J Seeger","year":"2017","unstructured":"Seeger J, Gonska B, Rodewald C et al (2017) Apixaban in patients with atrial fibrillation after transfemoral aortic valve replacement. JACC Cardiovasc Interv 10(1):66\u201374","journal-title":"JACC: Cardiovascular Interventions"},{"issue":"25","key":"3970_CR34","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1161\/CIRCULATIONAHA.113.006426","volume":"129","author":"L Di Biase","year":"2014","unstructured":"Di Biase L, Burkhardt JD, Santangeli P et al (2014) Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial. Circulation 129(25):2638\u20132644","journal-title":"Circulation"},{"issue":"1","key":"3970_CR35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3121\/cmr.2020.1546","volume":"19","author":"MU Siddiqui","year":"2021","unstructured":"Siddiqui MU, Pasha AK, Rauf I et al (2021) Efficacy and safety of perioperative bridging anticoagulation in patients with atrial fibrillation undergoing elective surgical procedures: a meta-analysis. Clin Med Res 19(1):19\u201325","journal-title":"Clin Med Res"},{"issue":"4","key":"3970_CR36","doi-asserted-by":"publisher","first-page":"381","DOI":"10.4244\/EIJY14M06_07","volume":"11","author":"WJ Dewilde","year":"2015","unstructured":"Dewilde WJ, Janssen PW, Kelder JC et al (2015) Uninterrupted oral anticoagulation versus bridging in patients with long-term oral anticoagulation during percutaneous coronary intervention: subgroup analysis from the WOEST trial. EuroIntervention 11(4):381\u2013390","journal-title":"EuroIntervention"},{"issue":"3","key":"3970_CR37","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v17.i3.104000","volume":"17","author":"A Goyal","year":"2025","unstructured":"Goyal A, Shoaib A, Fareed A (2025) Outcomes of periprocedural continuation vs interruption of oral anticoagulation in transcatheter aortic valve replacement. World J Cardiol 17(3):104000","journal-title":"World J Cardiol"},{"key":"3970_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11082190","author":"C Granger","year":"2022","unstructured":"Granger C, Guedeney P, Collet JP (2022) Antithrombotic therapy following transcatheter aortic valve replacement. J Clin Med 11(8).\u00a0https:\/\/doi.org\/10.3390\/jcm11082190","journal-title":"J Clin Med"},{"issue":"23","key":"3970_CR39","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1001\/jama.2019.7525","volume":"321","author":"CP Huded","year":"2019","unstructured":"Huded CP, Tuzcu EM, Krishnaswamy A et al (2019) Association between transcatheter aortic valve replacement and early postprocedural stroke. JAMA 321(23):2306\u20132315","journal-title":"JAMA"},{"key":"3970_CR40","doi-asserted-by":"crossref","unstructured":"Reddy P, Merdler I, Ben-Dor I et al (2024) Cerebrovascular events after transcatheter aortic valve implantation. Eurointervention 20(13):e793\u2013805","DOI":"10.4244\/EIJ-D-23-01087"},{"issue":"11","key":"3970_CR41","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1161\/STROKEAHA.124.047149","volume":"55","author":"KP Patel","year":"2024","unstructured":"Patel KP, Rathod KS, Lansky AJ et al (2024) Cerebrovascular events in patients undergoing transcatheter aortic valve replacement: a review. Stroke 55(11):2754\u20132764","journal-title":"Stroke"},{"key":"3970_CR42","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.115.002981","author":"S Kapadia","year":"2016","unstructured":"Kapadia S, Agarwal S, Miller DC et al (2016) Insights into timing, risk factors, and outcomes of stroke and transient ischemic attack after transcatheter aortic valve replacement in the PARTNER trial (Placement of Aortic Transcatheter Valves). Circ Cardiovasc Interv. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.115.002981","journal-title":"Circ Cardiovasc Interv"},{"issue":"17","key":"3970_CR43","first-page":"1285","volume":"38","author":"G Tarantini","year":"2017","unstructured":"Tarantini G, Mojoli M, Urena M et al (2017) Atrial fibrillation in patients undergoing transcatheter aortic valve implantation: epidemiology, timing, predictors, and outcome. Eur Heart J 38(17):1285\u20131293","journal-title":"Eur Heart J"},{"issue":"9","key":"3970_CR44","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.jcin.2016.01.037","volume":"9","author":"G Tarantini","year":"2016","unstructured":"Tarantini G, Mojoli M, Windecker S et al (2016) Prevalence and Impact of Atrial Fibrillation in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: An Analysis From the SOURCE XT Prospective Multicenter Registry. JACC Cardiovasc Interv 9(9):937\u2013946","journal-title":"JACC Cardiovasc Interv"},{"key":"3970_CR45","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ahj.2017.07.005","volume":"192","author":"M Mojoli","year":"2017","unstructured":"Mojoli M, Gersh BJ, Barioli A et al (2017) Impact of atrial fibrillation on outcomes of patients treated by transcatheter aortic valve implantation: a systematic review and meta-analysis. Am Heart J 192:64\u201375","journal-title":"Am Heart J"},{"issue":"10","key":"3970_CR46","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1002\/phar.2847","volume":"43","author":"PP Dobesh","year":"2023","unstructured":"Dobesh PP, Goldsweig AM (2023) Antithrombotic therapy with transcatheter aortic valve replacement. Pharmacotherapy 43(10):1064\u20131083","journal-title":"Pharmacotherapy"},{"issue":"12","key":"3970_CR47","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.rec.2024.06.001","volume":"77","author":"G Tirado-Conte","year":"2024","unstructured":"Tirado-Conte G, S\u00e1nchez-Recalde \u00c1, Zamorano JL (2024) Is DOAC the preferred oral anticoagulation therapy after TAVI? Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition) 77(12):985-986","journal-title":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"},{"issue":"2","key":"3970_CR48","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.clinthera.2023.09.028","volume":"46","author":"A Maznyczka","year":"2024","unstructured":"Maznyczka A, Pilgrim T (2024) Antithrombotic treatment after transcatheter valve interventions: current status and future directions. Clin Ther 46(2):122-133","journal-title":"Clin Ther"},{"issue":"4","key":"3970_CR49","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/clc.23793","volume":"45","author":"YF Chen","year":"2022","unstructured":"Chen YF, Liu F, Li XW et al (2022) Non-vitamin K oral anticoagulants versus vitamin K antagonists in post transcatheter aortic valve replacement patients with clinical indication for oral anticoagulation: a meta-analysis. Clin Cardiol 45(4):401\u2013406","journal-title":"Clin Cardiol"},{"key":"3970_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.755009","volume":"13","author":"D Li","year":"2022","unstructured":"Li D, Ma X, Zhou X et al (2022) Non-vitamin K oral anticoagulant after transcatheter aortic valve replacement: a systematic review and meta-analysis. Front Pharmacol 13:755009","journal-title":"Front Pharmacol"},{"key":"3970_CR51","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.amjcard.2023.06.049","volume":"201","author":"V Selvaraj","year":"2023","unstructured":"Selvaraj V, Khan MS, Mufarrih SH et al (2023) Meta-analysis assessing efficacy and safety of vitamin K antagonists versus direct oral anticoagulants for atrial fibrillation after transcatheter aortic valve implantation. Am J Cardiol 201:260-267","journal-title":"Am J Cardiol"},{"key":"3970_CR52","doi-asserted-by":"publisher","DOI":"10.1177\/10760296231158585","volume":"29","author":"WC Lee","year":"2023","unstructured":"Lee WC, Shih JY, Fang HY et al (2023) Comparing vitamin K antagonists and direct oral anticoagulants in patients with atrial fibrillation undergoing transcatheter aortic valve replacement: a meta-analysis. Clin Appl Thromb Hemost 29:10760296231158585","journal-title":"Clin Appl Thromb Hemost"},{"key":"3970_CR53","doi-asserted-by":"crossref","unstructured":"Al Said S, Kaier K, Nury E et al (2025) Non-vitamin K antagonist oral anticoagulants (NOACs) after transcatheter aortic valve replacement (TAVR): a network meta-analysis. Cochrane Database Syst Rev 2:CD013745","DOI":"10.1002\/14651858.CD013745.pub2"},{"issue":"10","key":"3970_CR54","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1007\/s00228-022-03371-6","volume":"78","author":"AJQ Ooi","year":"2022","unstructured":"Ooi AJQ, Wong C, Tan TWE et al (2022) A systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulants vs vitamin K antagonists after transcatheter aortic valve replacement in patients with atrial fibrillation. Eur J Clin Pharmacol 78(10):1589\u20131600","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"3970_CR55","first-page":"279","volume":"149","author":"LPT Joosten","year":"2024","unstructured":"Joosten LPT, van Doorn S, van de Ven PM et al (2024) Safety of switching from a vitamin K antagonist to a non-vitamin K antagonist oral anticoagulant in frail older patients with atrial fibrillation: results of the FRAIL-AF randomized controlled trial. Circulation 149(4):279\u2013289","journal-title":"Circulation"},{"issue":"3","key":"3970_CR56","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.jcin.2023.12.024","volume":"17","author":"JM Ten Berg","year":"2024","unstructured":"Ten Berg JM, Overduin DC, van Ginkel DJ (2024) What Oral Anticoagulant Is Best After TAVR: Vitamin K Antagonists or Direct Oral Anticoagulants? JACC Cardiovasc Interv 17(3):419\u2013421","journal-title":"JACC Cardiovasc Interv"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-025-03970-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-025-03970-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-025-03970-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T15:04:29Z","timestamp":1771859069000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-025-03970-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["3970"],"URL":"https:\/\/doi.org\/10.1007\/s00228-025-03970-z","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"9 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our research was conducted in accordance with the registration protocol,\n                      \n                      .","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"PROSPERO registration statement"}},{"value":"Not applicable (This is a meta-analysis article with no ethical requirements).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors declared that we had no conflict of interest with this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"60"}}